Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Hydroxychloroquine can help treat certain types of hair loss.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Reporter characteristics affect detection of hair loss from cancer therapy.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.